MedPath

Hepatectomy With or Without the Thoraco-abdominal Approach

Completed
Conditions
Surgery
Liver Tumors
Hepatectomy
Liver Resection
Interventions
Procedure: Hepatectomy
Registration Number
NCT03171428
Lead Sponsor
University of Milan
Brief Summary

The performance of hepatectomy for liver tumors using the thoraco-abdominal approach (TAA) versus the abdominal approach (AA) is still debated.

The aim of the study is the analysis of the perioperative outcome of patients operated with or without the TAA for liver tumors.

Detailed Description

The prospectively maintained database was queried. A 1:1 propensity score-matched analysis was applied. Among 744 patients, 246 undergoing hepatectomy with TAA and 246 undergoing hepatectomy with AA were compared. These patients were matched for baseline characteristics, underlying liver disease, comorbidity, tumor features, and extent of the resection. The rates of morbidity and mortality were the study endpoints.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
744
Inclusion Criteria
  • First liver surgery;
  • Any type of malignant liver tumor, including hepatocellular carcinoma on cirrhosis.
Exclusion Criteria
  • Previous history of liver surgery;
  • Any type of benign liver tumor;
  • Incomplete clinical, surgical, pathological or postoperative data;
  • Patients treated with radiofrequency ablation alone or in combination with surgery were also excluded.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
AAHepatectomyAbdominal Approach: those patients with liver tumors operated with the abdominal approach (without the thoracotomy)
TAAHepatectomyThoraco-Abdominal Approach: those patients with liver tumors operated with the thoracic-abdominal approach
Primary Outcome Measures
NameTimeMethod
Short-term outcome: Occurrence of postoperative complications or death after surgeryWithin 90-days after the operation

Occurrence of postoperative complications or death after surgery

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath